Originally published In Press as doi:10.1074/jbc.M000729200 on March 21, 2000
J. Biol. Chem., Vol. 275, Issue 23, 17754-17761, June 9, 2000
Analysis of the Role of the Hypervariable Region of Yeast Ras2p
and Its Farnesylation in the Interaction with Exchange Factors and
Adenylyl Cyclase*
Jean-Bernard
Créchet
,
Eric
Jacquet
,
Alberto
Bernardi§, and
Andrea
Parmeggiani¶
From the Groupe de Biophysique-Equipe 2, Ecole Polytechnique,
F-91128 Palaiseau Cedex, France and the § Populations,
Génétique et Evolution, Unité Propre de Recherche
n° 9034 du Centre Nationale de la Recherche Scientifique,
F-91198 Gif-sur-Yvette, France
Received for publication, January 28, 2000
 |
ABSTRACT |
Ras proteins from Saccharomyces
cerevisiae differ from mammalian Ha-Ras in their extended
C-terminal hypervariable region. We have analyzed the function of this
region and the effect of its farnesylation with respect to the action
of the GDP/GTP exchange factors (GEFs) Cdc25p and Sdc25p and the target
adenylyl cyclase. Whereas Ras2p farnesylation had no effect on the
interaction with purified GEFs from the Cdc25 family, this modification
became a strict requirement for stimulation of the nucleotide exchange on Ras using reconstituted cell-free systems with GEFs bound to the
cell membrane. Determination of GEF effects showed that in cell
membrane the Cdc25p dependent activity on Ras2p was predominant over
that of Sdc25p. In contrast to full-length GEFs, a membrane-bound C-terminal region containing the catalytic domain of Cdc25p was still
able to react productively with unfarnesylated Ras2p. These results
indicate that in membrane-bound full-length GEF the N-terminal moiety
regulates the interaction between catalytic domain and farnesylated
Ras2p·GDP. Differently from GEF, full activation of adenylyl cyclase
did not require farnesylation of Ras2p·GTP, even if this step of
maturation was found to facilitate the interaction. The use of
Ha-Ras/Ras2p chimaeras of different length emphasized the key role of
the hypervariable region of Ras2p in inducing maximum activation of
adenylyl cyclase and for a productive interaction with membrane-bound
GEF.
 |
INTRODUCTION |
Ras proteins are GTPases cycling between the active GTP-bound
state and the inactive GDP-bound state. They transmit extracellular signals that regulate cell growth and differentiation (1). The level of
activated Ras is controlled by the GTPase-activating protein and the
GDP/GTP exchange factor
(GEF)1 which in the case of
Saccharomyces cerevisiae are Ira1p/Ira2p (2, 3) and Cdc25p,
respectively (4). This organism harbors a second RasGEF (Sdc25p, Ref.
5) of unclear functions, that can complement Cdc25p (6-8). Ras1p and
Ras2p regulate the activity of adenylyl cyclase and
cAMP-dependent protein kinases (9). One major difference
between yeast and mammalian Ras proteins lies in their C-terminal
hypervariable region which in the case of Ras from the former organism
is much more extended (~120 versus ~20 aa residues). The
function of this overextended C-terminal region is as yet unclear.
Association with the cell membrane is an essential condition for the
function of Ras proteins. Translocation of Ras to the inner surface of
the membrane is promoted by sequential post-translational modifications
of the C-terminal CAAX consensus box (10). The first step,
the farnesylation of cysteine, is followed by proteolytic cleavage of
the AAX peptide, methyl-esterification of the exposed
isoprenylated cysteine and in the case of human N-Ras, Ha-Ras, and
S. cerevisiae Ras1p and Ras2p, palmitoylation of one or two
cysteines located upstream to the CAAX motif (11). After
farnesylation, AAX proteolysis and methylation, Ras proteins are still mainly cytosolic; their tight association with the plasma membrane requires palmitoylation (12-14) or for K-Ras a signal composed of a polybasic domain (14). In mammalians, farnesylation was
reported to be essential for the action of the ubiquitary exchange
factor SOS (15); it targets Raf to the cell membrane (16-19) and is
necessary for transformation (20). In yeast farnesylation of Ras2p was
found to be important for the interaction with the adenylyl cyclase-CAP
complex (21, 22). Information on the role of farnesylation in the
activity of yeast Cdc25p and Sdc25p is so far limited to the
observation that the isolated catalytic domain of Cdc25p promoted the
nucleotide exchange on prenylated Ras and even more strongly on
unprocessed Ras (15).
In this work we have analyzed the role of the C-terminal hypervariable
region of Ras proteins and its farnesylation in the interaction with
both full-length exchange factors Cdc25p and Sdc25p, and in the
activation of adenylyl cyclase. As methodological approach, a well
defined reconstituted in vitro system using membrane preparations from isogenic yeast strains was utilized in order to mimic
in vivo conditions and compensate for the fact that the isolated full-length Cdc25p and Sdc25p are not yet available despite considerable efforts. In this context the activities of these two GEFs
as components bound to the cell membrane were characterized and
compared with the activity of membrane-bound GEF C-terminal region. The
obtained results have further enlighted the regulatory role of the
N-terminal region of GEF on the C-terminal catalytic domain and
demonstrated the absolute requirement of Ras2p farnesylation for a
productive interaction. The construction of Ha-Ras/Ras2p chimaeras has
selectively defined the importance of the hypervariable region of yeast
Ras for the activation of adenylyl cyclase.
 |
EXPERIMENTAL PROCEDURES |
Media, Plasmids, and Yeast Methods--
The standard rich medium
used was YEPD (2% bacto-peptone, 1% yeast extract, and 2% dextrose).
Selective synthetic media contained 0.67% yeast nitrogen base without
amino acids (Difco) supplemented with all the auxotrophic requirements
as described (23) and 2% dextrose or 3% glycerol or 2% raffinose
plus 4% galactose. pFC1 (8), pYEDP1/8/2 (24), and pIND25-1 (25) are
yeast vectors for the expression of full-length SDC25,
CDC25 genes, and the 3' CDC25 terminal fragment
(residues 877-1589), respectively. pYACE1 (26) is a vector
overproducing wild-type adenylyl cyclase CYR1 gene product.
The dimethyl sulfoxide-modified version (27) of the Li-acetate method
(28) was carried out for yeast transformation with either plasmid DNA
or purified DNA fragments (10-20 µg) using 0.1 M NaCl/TE
instead of TE alone for the preparation of yeast competent cells. The
vectors pYEDP1/8/2, pIND25-1, and pYACE1 allowed expression in yeast
under the control of the galactose inducible GAL10-CYC1
hybrid promoter. Yeast strains transformed by these plasmids were grown
at 30 °C on minimal selective medium using 2% raffinose as a carbon
source to a cell density of 0.15 A600 units and
then induced with galactose (final concentration: 4%). Total yeast DNA
was prepared as described in Ref. 29.
Yeast Strains--
The genotypes of the yeast strains used are
listed in Table I. The
sdc25
CDC25 ras1
ras2
CRI4 (AAT3B-
S25) and
sdc25
cdc25
ras1
ras2
CRI4
(AAT3B-
2) strains were engineered by replacing the SDC25 genes of strains AAT3B and AAT3B-
1, respectively, with a disrupted sdc25::HIS3 allele. For this, the linearized
pGEX2T SDC25 plasmid (32) carrying a 424-base pair
BglII-BglII deletion of the 3'-SDC25 open reading frame was purified and ligated with a 1.25-kb
BamHI-BamHI fragment derived from
yDp-H (33), containing the HIS3 marker. The
unique EcoRI site located at the C terminus of
SDC25 was replaced by a SalI site. The purified
2.7-kilobase XbaI-SalI fragment (10-20 µg)
from this vector was used to transform AAT3B and AAT3B-
1 competent
cells by homologous recombination. Transformants were selected on
synthetic medium by histidine or leucine and histidine prototrophy,
respectively. The integration events were mapped by Southern blot
analysis on HindIII-EcoRI-digested genomic DNA using a 1124-base pair HaeIII fragment spanning the 3'
terminal region of the gene as a probe.
The replacement of the ras2::URA3 chromosomal gene
in strain AAT3B-
2 by the ras2::HIS3 allele gave
rise to strain AAT3B-
2R2H. This replacement of the original
disruption marker was required to facilitate further selection for
URA+ transformants with pYEDP1/8/2, pIND25-1, or
pFC1 plasmids. Conversion of URA3 with the HIS3
disruption marker was carried out with the one-step strategy (34) using
the pUH7 marker swap plasmid. AAT3B-
2 competent cells were
transformed with linearized SmaI-pUH7 fragment containing an
URA3 gene disrupted with the HIS3 marker.
HIS+ transformants were counter-selected for the
marker URA3 using 5-fluoroorotic acid (35). The replacement
of ras2::URA3 by ras2::HIS3 was confirmed by Southern blot analysis of HindIII-digested
genomic DNA transformants using a EcoRI-HindIII
32P-labeled probe containing the genomic RAS2
wild-type gene and its flanking sequences.
Preparation of the Different Ras and CDC25GEF
Proteins--
"Ras proteins" is a general term used in this work
for designating human Ha-Ras p21, S. cerevisiae Ras2p, and
Ha-Ras/Ras2p chimeric products. cHa-Ras p21 and full-length Ras2p were
purified as described in Ref. 36. The two chimaeras Ha-Ras 1-173/Ras2p 307-322 and Ha-Ras 1-173/Ras2p 182-322 were constructed with the same method used for the Ha-Ras1-81/Ras2p 89-322 chimaera (37) and
were expressed as glutathione S-transferase fusion proteins in Escherichia coli SCS1. Affinity chromatography on
glutathione-agarose and thrombin treatment removing the N-terminal
fused glutathione S-transferase were carried out as for
Ras2p. Mono-Q HR5/5 chromatography (FPLC system, Amersham Pharmacia
Biotech) with a linear 20-230 mM KCl gradient (50 ml) in
25 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 7 mM
-mercaptoethanol, and 10 µM GDP)
allowed the separation of full-length proteins from the C-terminal
truncated forms of Ras2p. The C-terminal catalytic domain of Sdc25p
(C-Sdc25p, 550 aa), Cdc25p (C-Cdc25p, 509 aa), CDC25Mm
(C-CDC25Mm, 285 aa) were purified as described (36) and the
full-length CDC25Mm (1262 aa) was obtained as N-terminal fusion
with the maltose-binding protein (38).
Purification of Farnesyl-Protein Transferase--
E.
coli JM 101 containing the plasmid pGP14-2/1/2 (39) was used to
express the coupled S. cerevisiae RAM1/RAM2 gene products encoding farnesyl transferase (FTase). The transformed strain was grown
at 24 °C in 4 liters of LB-rich medium with 50 µg
ml
1 ampicillin and induced at a cell density of 0.5 A600 with 0.1 mM
isopropyl-
-D-thiogalactopyranoside. After 12-15 h, the
cells were collected by centrifugation, washed, and sonicated four
times for 30 s at 4 °C in 100 ml of buffer A (25 mM
Tris-HCl, pH 7.8, 10 µM ZnCl2, 1 mM MgCl2, 1 mM dithiothreitol)
containing 80 mM NaCl, 1 mg ml
1 lysozyme, 100 µg ml
1 DNase (Roche Molecular Biochemicals), and
protease inhibitors (2 mM Pefablock S-C, 1.7 µg
ml
1 pepstatin, 2.5 µg ml
1 aprotinin, 1 µg ml
1 leupeptin; Roche Molecular Biochemicals).
Supernatant from 2 h centrifugation at 140,000 × g was loaded on a HiPrep 16/10 Source 30Q column (Amersham
Pharmacia Biotech). The most active fractions eluted between 180 and
250 mM NaCl in buffer A were applied to an affinity
chromatographic support carrying the hexapeptide TKCVIM (corresponding
to the C-terminal residues of K-RasB) and purified (40). The collected
active eluted fractions (~50% pure) were concentrated by
ultrafiltration and stored in buffer A with 50% glycerol at
20 °C.
Farnesyl-Protein Transferase Assay--
FTase activity was
tested by measuring the amount of [3H]farnesyl moiety
transferred from [3H]farnesyl pyrophosphate (Fpp,
Isotopchim) to intact purified Ras products. The standard reaction
mixture contained in 50 mM Tris-HCl, pH 7.8, 10 µM ZnCl2, 2.5 mM
MgCl2, 0.25 mM CaCl2, 5 mM dithiothreitol (farnesylation buffer), 10 µM GDP, 5 µM Ras proteins, and 70 µM [3H]Fpp (specific activity: 694 MBq
mmol
1). The reaction was started with 0.3-1
µM purified FTase. After 45 min at 30 °C, an aliquot
was applied to glass fiber filter (MFS, Advantec GASS) and the reaction
stopped in 1 M HCl/ethanol at 0 °C. Filters were washed
4 times with cold ethanol, dried, and counted in a Wallac 1410 liquid
scintillation spectrometer. The blank values obtained without Ras were subtracted.
Preparation of in Vitro Farnesylated Ras--
GDP, GTP, or
GTP
S-bound Ras products (4 µM) were farnesylated by a
45-min incubation at 30 °C in farnesylation buffer with 0.5 µM purified FTase, 100 µM cold Fpp
(Isotopchim) and in the presence of a protease inhibitors mixture (2 µg ml
1 aprotinin, 1 µg ml
1 leupeptin,
60 µg ml
1 antipain, 2 mM Pefablock S-C,
Roche Molecular Biochemicals). Level of farnesylation of the various
Ras products using [3H]Fpp as substrate was analyzed by
electrotransfer to Nytran-N membrane (Schleicher & Schuell) from a
12.5% SDS-PAGE followed by autoradiography of the membrane pretreated
with intensifier EN3HANCE (NEN Life Science Products Inc.).
Determination of Ras·[3H]GDP Dissociation
Rates--
Preformed Ras·[3H]GDP complexes were
prepared by incubating for 15 min at 30 °C, 9 µM
Ras·GDP in 25 mM Tris-HCl, pH 7.5, 5 mM EDTA,
1 mM dithiothreitol, and 0.05 mg ml
1 bovine
serum albumin with 20 µM [3H]GDP (200 GBq
mmol; NEN Life Science Products Inc.). The preformed labeled complexes
were then farnesylated as described above. Control unfarnesylated
Ras·[3H]GDP complexes were treated identically but
omitting the FTase. The dissociation rate constants
(k
1) of Ras·[3H]GDP complexes
were determined at 30 °C by the nitrocellulose binding assay (36).
The 70-µl reaction mixture with or without GEF as indicated in the
legends to tables contained in 50 mM Tris-HCl, pH 7.5, 65 mM NH4Cl, 1 mM dithiothreitol, 0.05 mg ml
1 bovine serum albumin, 1 mM
MgCl2, 200 nM farnesylated or unfarnesylated preformed Ras·[3H]GDP complex and a 1000-fold excess of
unlabeled GDP. The reaction was started with
Ras·[3H]GDP complex. At time intervals, aliquots (10 µl) were filtered on nitrocellulose discs that were then washed twice
with 3 ml of ice-cold 50 mM Tris-HCl, pH 7.5, 100 mM NH4Cl, 10 mM MgCl2, 7 mM
-mercaptoethanol. The filters were then counted for radioactivity.
Adenylyl Cyclase Assay--
The adenylyl cyclase assay was
carried out as described (41). Yeast membranes were prepared from cells
grown in their respective selective medium (36) and collected at a cell
density of 1.5 A600 units and used as source of
membrane-associated adenylyl cyclase and GEF (Cdc25p, Sdc25p, or both
factors). The cAMP production was determined after 18 min at 30 °C
at which time the reaction was linear. The 100-µl reaction mixture,
with the indicated concentrations of farnesylated or unfarnesylated Ras
proteins in their preformed GDP, GTP, or GTP
S complex, contained
either 30-40 µg of membrane preparation for the yeast strains
expressing the CRI4-encoded adenylyl cyclase (CRI4-adenyl
cyclase) gene or 3.5 µg of membrane preparation for the yeast strain
TS1-6 which harbors an overexpression vector for the wild-type adenylyl
cyclase gene (CYR1). These amounts of membranes in the assay
gave similar levels of Ras-uncoupled adenylyl cyclase activity as
determined in the presence of 1.5 mM MnCl2.
Preformed Ras·GDP, GTP, or GTP
S complexes were obtained in the
presence of 0.5 mM of the corresponding unlabeled guanine nucleotide and farnesylated as described above. Unprenylated complexes were treated identically but omitting the FTase. The reaction was
started with a mixture containing 50 mM MES, pH 6.2, 5 mM MgCl2, GTP, or GTP
S (0.5 mM),
cAMP (0.5 mM), [
-32P]ATP (0.3 mM, 5 GBq mmol
1), theophylline, creatine
phosphate, and creatine kinase.
Other Methods--
Protein concentration were measured by the
Bio-Rad protein assay or in the case of yeast membranes by the Lowry
method (42), using bovine serum albumin as a standard. SDS-PAGE was
carried out using a 12.5% acrylamide separating gel. DNA probes were
32P-labeled with the Megaprime DNA labeling system from
Amersham Pharmacia Biotech.
 |
RESULTS |
Properties of the Biological Components--
The properties of the
biological components used in this work were carefully characterized.
The experiments involving yeast membranes were carried out with
different membrane preparations in order to assure reproducibility of
the results. Fig. 1 illustrates the forms
and constructs of Ras used for our experiments. They were at least 90%
pure on Coomassie Blue-stained SDS-PAGE (Fig. 2A) and stable for at least
several months when kept at
20 °C in storage buffer (36). It is
important to emphasize that all purified Ras species displayed a molar
stoichiometric GDP or GTP binding close to one. Fig. 2B
illustrates the farnesylation of the various Ras species after
electro-transfer using [3H]Fpp as substrate. The FTase
assay showed that farnesylation of the Ras species was complete; 1 mol
of farnesyl group was found to be bound per mole of intact Ras
product.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Diagram of the various Ras constructs.
The solid bars indicate regions originating from Ha-Ras and
the open bars refer to those from Ras2p.
|
|

View larger version (109K):
[in this window]
[in a new window]
|
Fig. 2.
Coomassie Blue-stained SDS-PAGE of various
purified Ras constructs (A) and autoradiography of
3H-farnesylated Ras products after electrotransfer onto
membrane (B). A, the samples contain
0.7 µg of Ha-Ras (lane 1), Ha-Ras 1-173/Ras2p 307-322
(lane 2), Ras2p (lane 3), Ha-Ras 1-81/Ras2p
89-322 (lane 4), Ha-Ras 1-173/Ras2p 182-322 (lane
5), and 4 µg of markers (Amersham Pharmacia Biotech) with the
indicated molecular mass (kDa (lane 6)). B, each
lane contains 0.5 µg of Ras product after the farnesylation reaction
using 8 µM [3H]Fpp as donor of farnesyl
group (832 GBq/mol) ("Experimental Procedures"). Ha-Ras (lane
1), Ha-Ras 1-173/Ras2p 307-322 (lane 2), Ras2p
(lane 3), Ha-Ras 1-81/Ras2p 89-322 (lane 4),
Ha-Ras 1-173/Ras2p 182-322 (lane 5), and 6 µg of
prestained SDS-standard markers (Bio-Rad) with the indicated molecular
mass (kDa).
|
|
The catalytic domains of Sdc25p (C-Sdc25p, 550 aa) and CDC25Mm
(C-CDC25Mm, 285 aa) were pure, and Cdc25p (C-Cdc25p, 509 aa)
>50% pure. The purified full-length CDC25Mm (1262 aa),
obtained as N-terminal fusion with the maltose-binding protein was at
least >50% pure, the contamination consisting of its C-terminal
truncated forms (38). All of these GEFs were stable for several months
when conserved under the same conditions as the various Ras species.
In Vitro Farnesylation of Ras2p Does Not Influence the
Cdc25GEFdependent GDP Dissociation
Rate--
Farnesylation in vitro allows a detailed analysis
of partially processed Ras avoiding the introduction of mutations into
the site for palmitoylation of Ras2p and the use of detergents for solubilization of processed Ras proteins from cell extract. Both these
procedures could affect the interaction with Ras ligands.
At first, we examined whether in vitro farnesylation of
Ras2p affected the intrinsic interaction with GDP and the GDP
dissociation rate mediated by Cdc25p and Sdc25p catalytic domains but
no effect was found (Table II),
differently from the observations of other authors using the catalytic
domain of Cdc25p (15). Because the specific activities of these various
GEF catalytic domains are different (43), their concentration in the
assays was adjusted to give a comparable stimulation on the Ras2p·GDP
dissociation rate. Full-length Cdc25p and Sdc25p could not be tested
because their isolation has as yet to be achieved. However, differently from a report on full-length SOS (15) we were unable to see any
enhancement by farnesylation of the activity of full-length, purified
mouse CDC25Mm or of its catalytic domain C-CDC25Mm
(Table II).
View this table:
[in this window]
[in a new window]
|
Table II
In vitro farnesylation of Ras2p does not influence
Cdc25GEF-dependent GDP dissociation rate
The reaction was performed as described under "Experimental
Procedures" with 6 nM C-Cdc25p, 48 nM
C-Sdc25p, 80 nM C-CDC25Mm, and 230 nM
full-length CDC25Mm and was started with 200 nM
farnesylated or unprenylated Ras2p·[3H]GDP complex.
|
|
Farnesylation of Ras2p Is Strictly Required for the Nucleotide
Exchange Activity Mediated by Membrane-bound Cdc25p or Sdc25p--
The
complete disruption of both RAS1 and RAS2 genes
or of the CDC25 gene is lethal (6, 44, 45). However,
introduction of the CRI4 mutation (T1651I, Ref. 46) into
adenylyl cyclase gene bypasses the requirement for both RAS
and CDC25 genes via the constitutive production of low
levels of cAMP. CRI4-adenylyl cyclase activity is still strongly
stimulated by Ras·GTP proteins in vivo and in
vitro (26, 46). To take advantage of these properties, we have
used a set of isogenic yeast strains in a CRI4 and
ras1
, ras2
background. Starting from strain AAT3B, strains were constructed, in
which CDC25 (AAT3B-
1), SDC25 (AAT3B-
S25) or
both these genes (AAT3B-
2) were disrupted. It is essential to stress
that measurement of Ras nucleotide exchange dependent on membrane-bound
Cdc25p or Sdc25p cannot be directly determined by the classical methods on nitrocellulose or gel filtration, as a likely consequence of the
inherent properties of the association between exchange factors and
cell membrane. For this reason, in most our experiments the exchange
activity on Ras was followed indirectly in a reconstituted adenylyl
cyclase assay. The validity of this method was proved in previous work
(41). Membrane preparations from AAT3B, AAT3B-
1, AAT3B-
S25, and
AAT3B-
2 were used as a source of adenylyl cyclase in combination
with either Cdc25p or Sdc25p, or both GEFs for in vitro
assays in which purified intact Ras2p was added exogenously. This
hybrid in vitro system reproduces in vivo
conditions in which Cdc25p or Sdc25p are anchored to the membrane. We
could so analyze selectively the effect of the membrane-associated
GEF(s) on increasing concentrations of unfarnesylated or farnesylated
Ras2p·GDP via the extent to which the generated Ras·GTP could
activate adenylyl cyclase.
Fig. 3A confirms that
unfarnesylated Ras2p·GDP was unable to activate adenylyl cyclase
whatever membrane preparation was used and shows that restoration of
adenylyl cyclase is strictly dependent on farnesylation of Ras2p·GDP.
The stimulation was slightly reduced when only Cdc25p was present as
compared with membranes carrying both Cdc25 and Sdc25 products. The
presence of Sdc25p alone stimulated markedly less than Cdc25p. The low
but relevant residual cAMP production observed in the absence of GEF
corresponds to the intrinsic regeneration of prenylated active complex.
In agreement with this is the observation that preformed prenylated
Ras2p·GTP
S complex interacts more efficiently with adenylyl
cyclase than the unprenylated Ras2p·GTP
S complex (Fig.
3B). Therefore, the possibility of the existence of another
low-expressed membrane-bound exchange activity sounds rather
unprobable. Taking the extent of activation as a measure for the
productive interaction between Ras2p and adenylyl cyclase, the
concentrations inducing half-maximum activation
(Ka), were calculated to be 7 nM for
prenylated Ras2p and 100 nM for the unprocessed form
whatever the source of yeast strain membranes. This indicates that
neither Cdc25p nor Sdc25p can influence the interaction between
Ras2p·GTP and the target adenylyl cyclase.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Dependence on farnesylation of Ras2p for
exchange activity promoted by membrane-associated GEFs
(A) and its effect on adenylyl cyclase interaction
(B). Adenylyl cyclase activity was measured as a
function of increasing concentrations of purified full-length
Ras2p·GDP (A) or of preformed Ras2p·GTP S complex
(B) as unfarnesylated (filled symbols) or
farnesylated form (empty symbols) in the presence of
membranes from strain AAT3B containing both Cdc25p and Sdc25p ( ,
), AAT3B- S25 with only Cdc25p ( , ), AAT3B- 1 with only
Sdc25p ( , ) and AAT3B- 2 lacking both GEFs ( , ). The
background activity of membranes in the absence of Ras2p was
subtracted. Data are mean ± S.E. of values from four independent
experiments using different preparations for each yeast strain.
Error bars smaller than the symbols are not shown. Standard
deviations of panel B are expressed in Table III.
|
|
Differently from Intact Yeast GEF, Farnesylation of Ras2p Is Not
Required for the Exchange Activity Dependent on Membrane-coupled
C-terminal Region of Cdc25p--
For a more detailed investigation of
the specific effects of Ras2p farnesylation on the response to GEF, we
have transformed a yeast strain depleted of genomic CDC25
and SDC25 with pYEDP1/8/2, pFC1, or pIND25-1 overexpressing
full-length Cdc25p and Sdc25p, and the C-terminal region of the former
(C-Cdc25p 877-1589), respectively. Figs.
4, A and B, confirm
the strict dependence on farnesylation of Ras2p·GDP for the
regeneration of the active complex mediated by overexpressed
membrane-associated Cdc25p or Sdc25p. In both conditions, saturation
curves were similar showing that farnesylated Ras2p can react with the
same efficiency with either exchange factor.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Farnesylation of Ras2p is a specific
requirement for full-length Cdc25p and Sdc25p but not for the catalytic
domain of Cdc25p-dependent exchange activity. Adenylyl
cyclase activity dependent on the regeneration of Ras2p·GTP complex
mediated by yeast GEFs was analyzed as a function of increasing
concentrations of farnesylated ( ) and unfarnesylated ( )
Ras2p·GDP complex in the presence of membranes from strain
AAT3B- 2R2H overexpressing either full-length Cdc25p (A),
full-length Sdc25p (B), or the catalytic domain of Cdc25p
(C) under the conditions described under "Experimental
Procedures." The background activity of membranes in the absence of
Ras2p was subtracted. Data are mean ± S.E. of values from three
independent experiments using different membrane preparations for each
yeast strain. Errors bars smaller than symbols are not
shown.
|
|
Differently from membrane-bound intact GEF, farnesylation is not
required for the exchange activity if a membrane-associated GEF lacking
the N-terminal moiety (C-Cdc25p 877-1589) is used (Fig.
4C). In this case, Ras2p·GDP can rapidly be converted to its activated form even if unprenylated. With prenylated Ras2p, the
saturation curve was similar to that observed with membrane-bound full-length Cdc25p. In conclusion, the requirement of Ras2p
farnesylation for activation by membrane-associated intact GEF appears
not to be the consequence of membrane targeting of Ras2p, since the
C-terminal region of Cdc25p can react to the same extent with
unfarnesylated or farnesylated form of Ras2p. The dependence on
farnesylation is a selective property inherent in the
membrane-associated full-length Cdc25p, indicating that the N-terminal
moiety specifically controls the interaction with farnesylated Ras2p.
The same is probably valid also for Sdc25p.
Comparison of the Activation of Adenylyl Cyclase by Ras2p and
Ha-Ras--
The reconstituted cell-free system described in the
previous sections would make possible a precise analysis of the impact of farnesylation of Ras2p and Ha-Ras, if fully farnesylated Ha-Ras p21
were available. Unfortunately, in contrast to Ras2p, all our attempts
to farnesylate in vitro a high percentage of recombinant Ha-Ras were unsuccessful, at most 10% Ha-Ras p21 being farnesylated. This low level of farnesylation is a probable consequence of a partial
degradation of the C-terminal extremity of Ha-Ras. To overcome this
handicap, we constructed a modified Ha-Ras in which the last 16 C-terminal residues were replaced by the last 16 residues of Ras2p.
Fig. 2B shows that this construct designated Ha-Ras 1-173/Ras2p 307-322 can be fully farnesylated. Ha-Ras 1-173/Ras2p 307-322 can activate CRI4-adenylyl cyclase and its affinity for adenylyl cyclase is increased by prenylation, like Ras2p (Fig. 5A). However, the maximal
efficiency (Vmax) of Ha-Ras 1-173/Ras2p 307-322, as measured by determining the cAMP synthesized as a function
of increasing concentrations of the various Ras proteins, prenylated or
unprenylated, was different from Ras2p, the latter being 2.4-fold more
efficient. The Ka values show that the affinity of
prenylated Ras2p for CRI4-adenylyl cyclase is 8 times
stronger than that of prenylated Ha-Ras 1-173/Ras2p 307-322 (6.8 versus 55 nM; Table
III), whereas the affinities of the
corresponding unprenylated proteins are not very different (100 versus 178 nM, respectively). The requirement
for farnesylation is even more evident in the case of activation of the
wild-type CYR1 gene product (Fig. 5B) that showed
a maximal level of activation 6-fold higher with farnesylated Ras2p
than with farnesylated Ha-Ras. The deduced Ka values
were 26 and 100 nM, respectively (Table III). The ability
of unprenylated Ras2p to interact with CYR1 gene product was
very low (Ka > 800 nM, Table III),
unprenylated Ha-Ras 1-173/Ras2p 307-322 being nearly unable to induce
any cAMP production.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Comparative responses of CRI4
(A) and CYR1
(B) adenylyl cyclase gene products to
Ha-Ras·GTP S and
Ras2p·GTP S complexes in their prenylated or
unprenylated form. Activation of adenylyl cyclase CRI4
(A) and CYR1 (B) gene product were
compared as a function of increasing concentration of unprenylated
(filled symbols) or prenylated (empty symbols)
form of Ras2p ( , ), Ha-Ras (Ha-Ras 1-173/Ras2p 307-322) ( ,
) complexed with GTP S. The assays were performed as described in
the legend to Fig. 3 using 30-35 µg of membranes from indifferently
strain AAT3B or AAT3B- 2 (A) or 3.5 µg of membrane from
yeast strain TS1-6 overexpressing wild-type adenylyl cyclase
(B). The background activity of membranes in the absence of
Ras2p was subtracted. The results shown are the average of three
independent experiments. Standard errors are expressed in the derived
Table III.
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Ka and Vmax of CRI4 and CYR1 gene products for the
various Ras species
Values were calculated from double-reciprocal plots. The
Ka values represent the concentration of Ras giving
a half-maximal activity of adenylyl cyclase.
|
|
The Hypervariable Region of Ras2p Is Required for Full Adenylyl
Cyclase Activation while Its Farnesylation Increases the Efficiency of
the Interaction--
The primary structures of Ha-Ras and Ras2p
display domains with differing homology. The N-terminal domains
(residues: 1-81 in Ha-Ras and 8-88 in Ras2p) show a 90% homology,
the middle domains (82-173 in Ha-Ras and 89-181 in Ras2p) a 50%
homology, whereas no similarity exists in the C-terminal regions except
for the CAAX box (47). Having observed that Ras2p is a
better activator of adenylyl cyclase than Ha-Ras, we tried to determine
what region of the C-terminal moiety of Ras2p was involved in this
effect. For this, we constructed two chimaeras: Ha-Ras 1-81/Ras2p
89-322 containing in addition to the N-terminal domain of Ha-Ras the Ras2p middle domain (50% homology with Ha-Ras) and its hypervariable C-terminal region, and Ha-Ras 1-173/Ras2p 182-322 containing only the
hypervariable region of Ras2p.
These two constructs, which binds stoichiometrically GDP and GTP and
are fully farnesylated, showed the same intrinsic dissociation rate
values for GDP (Table IV),
i.e. slower than that of Ras2p (1.1 × 10
2 min
1 versus 1.83 × 10
2 min
1) and close to that of Ha-Ras p21;
also their response to C-Cdc25p (509 aa) being similar. Therefore,
these two constructs conserved the inherent properties of Ha-Ras.
Concerning the cAMP production as a function of unprenylated
Ras·GTP
S concentrations, Fig. 6 shows that the presence of the two C-terminal Ras2p domains can both
increase Vmax and affinity of Ha-Ras for
CRI4 adenylate cyclase to the levels observed with Ras2p
(Table III).
View this table:
[in this window]
[in a new window]
|
Table IV
Comparison of the dissociation rate constants of GDP of the various Ras
constructs in the absence and the presence of C-Cdc25p (509 aa)
The reaction was carried out as described in the legend to Table II
with the various Ras·[3H]GDP complex (final concentration:
200 nM) in the absence or presence of 6 nM
catalytic domain of Cdc25p.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Specific involvement of the C-terminal region
of Ras2p for maximal adenylyl cyclase activation. Adenylyl cyclase
activation was measured as a function of increasing concentrations of
GTP S complexes of unfarnesylated Ras2p ( ), Ha-Ras (Ha-Ras
1-173/Ras2p 307-322) ( ), Ha-Ras 1-81/Ras2p 89-322 ( ), and
Ha-Ras 1-173/Ras2p 182-322 ( ) as described in the legend to Fig.
3. The results represent three independent experiments performed in the
presence of membranes from either strain AAT3B or AAT3B- 2 as source
of the CRI4 gene product. For standard errors, see the
derived Table III. The background activity of membranes in the absence
of Ras2p was subtracted.
|
|
Experiments were carried out to compare the profiles of activation of
CRI4 (Fig. 7, panel
A) and CYR1 (Fig. 7, panel B) gene products
with increasing concentrations of the various prenylated Ras forms.
With both farnesylated chimaeras, the saturation levels were comparable
to that with farnesylated Ras2p. This result emphasizes the role of the
extended C-terminal region of Ras2p for maximum activation of adenylyl
cyclase. The extent of activation is particularly evident with the
CYR1 product, since the two fused domains of Ras2p increased
by 5-6 times the value of Vmax observed with
farnesylated Ha-Ras. The affinity constants estimated from inverse
plots of these experiments are summarized in Table III. Farnesylated
Ha-Ras/Ras2p chimaeras show affinity constants identical to those of
farnesylated intact Ras2p for the CRI4 (7-8 nM)
and CYR1 gene (26-38 nM) products. Comparison
of the Vmax and Ka values of
prenylated and unprenylated Ras strongly suggests that the C-terminal
region of Ras2p encompassing residues 173-307 includes specific
structures important for the activation of adenylyl cyclase, whereas
farnesylation is mainly involved in promoting the efficiency of the
interaction.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Importance of the C-terminal region of Ras2p
and its farnesylation for optimal activation of CRI4
(A) and CYR1
(B) adenylyl cyclase. Reconstituted
adenylyl cyclase activity was determined as function of increasing
concentrations of the various farnesylated Ras products in their active
GTP S complex form: Ras2p ( ), Ha-Ras (Ha-Ras 1-173/Ras2p
307-322) ( ), Ha-Ras 1-81/Ras2p 89-322 ( ), and Ha-Ras
1-173/Ras2p 182-322 ( ) in the presence of 30-35 µg of membranes
from either AAT3B or AAT3B- 2 yeast strain as a source of
CRI4 adenylyl cyclase activity (A) or 3.5 µg of
membranes from yeast strain TS1-6 overexpressing CYR1 gene
as a source of wild type adenylyl cyclase (B).The background
activity of membranes in the absence of Ras2p was subtracted. The
results shown are the average of three independent experiments.
Standard errors are expressed in the derived Table III.
|
|
Elements Determining the Sensitivity of Ras to the
Membrane-associated Catalytic Domain and Full-length
Cdc25p--
We have also analyzed the sensitivity of
Ha-Ras/Ras2p chimaeras to membrane-bound Cdc25p or C-Cdc25p 877-1589
using the adenylyl cyclase reconstitution assay. Increasing
concentrations of the different Ras·GDP constructs were used in their
unprenylated and prenylated form. Fig.
8A shows that full-length
Cdc25p can fulfill its exchange activity not only on Ras2p but also on
the various Ha-Ras/Ras2p chimaeras with high efficiency, provided that
these products were farnesylated. Differently from unprenylated Ras2p, unprenylated Ha-Ras 1-173/Ras2p 307-322 was unable to respond to
membrane associated C-Cdc25p (Fig. 8B). However, the fusion to the different N-terminal moieties of Ha-Ras with the complementing C-terminal region of Ras2p, as shown with the two chimaeras Ha-Ras 1-81/Ras2p 89-322 and Ras 1-173/Ras2p 182-322, restored
the sensitivity with the same efficiency as for unfarnesylated
Ras2p. The results indicate that structural elements of the
C-terminal hypervariable region of Ras2p are required for a
productive interaction with membrane-bound C-Cdc25p
877-1589.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Comparison between membrane associated
full-length (A) and its catalytic domain
(B) for exchange activity on various Ras
products. Elements determining their sensitivity. Reconstituted
adenylyl cyclase activity dependent on the regeneration of Ras·GTP by
overproduced membrane-associated Cdc25p (A) or its catalytic
domain (B) was determined as function of increasing
concentrations of unfarnesylated (filled symbols) or
farnesylated (empty symbols) forms of Ras2p ( , ),
Ha-Ras 1-173/Ras2p 307-322 ( , ), Ha-Ras 1-81/Ras2p 89-322
( , ) and Ha-Ras 1-173 Ras2p 182-322 ( , ) with membranes
from yeast strain AAT3B- 2R2H transformed with pYEDP 1/8/2 in
A or with pIND25-1 in B, as also described in
legend to Fig. 3. The background activity of membranes in the absence
of Ras2p was substracted. Three independent experiments were carried
out giving equivalent results.
|
|
 |
DISCUSSION |
The reconstituted cell-free system used in this study reproduces
in vitro the physiological conditions of the interaction between Ras and GEFs or adenylyl cyclase as cell membrane-bound components. Our observation that farnesylation of Ras2p did not affect
the GDP dissociation mediated by purified catalytic domains of yeast
GEFs or full-length CDC25Mm emphasizes the need for a system in
which these Ras ligands are associated with the cell membrane to study
physiologically relevant interactions. The use of CRI4 adenylyl cyclase
strains allowed the isolation of Ras- and GEF-free membranes, and
enabled the selective study of the effect of Ras2p farnesylation on
Cdc25p or Sdc25p interaction by bypassing the lethality of the
deletions. In this system the activity of membrane-associated
full-length GEFs was strictly dependent on farnesylation of Ras2p. A
relevant residual exchange activity was observed in membranes from
strains with disrupted CDC25 gene, that was also strictly
dependent on farnesylation of Ras2p and could be attributed to Sdc25p.
For the first time, it was so possible to define the extent of
cell-membrane exchange activity dependent on Sdc25p acting as a second
yeast GEF. Genetic analysis has shown that the SDC25 gene
can functionally complement a cdc25 mutation and that the
SDC25 and CDC25 genes are differently
transcribed, the former being expressed late during growth (8). The
same Km and Vmax of membranes
with overproduced Cdc25p or Sdc25p strongly suggests that the weaker activity of Sdc25p versus Cdc25p in native yeast membranes
is related to a low level of expression.
Sdc25p and Cdc25p are associated with the membrane via hydrophobic
sequences located in the C-terminal region (7, 48). Membrane-associated
overexpressed C-Cdc25p 877-1589 was found in this work to convert
farnesylated Ras2p·GDP to the active state, as do membranes with
intact Cdc25p or Sdc25p, but differently from these, it did not require
farnesylation of Ras2p to stimulate the exchange activity. This shows
that farnesylation is not involved in increasing the association of
Ras2p with the cell membrane but favors specific protein-protein
interactions. In fact, it is known that farnesylation is not sufficient
for a stable anchoring of Ras to the plasma membrane, palmitoylation of
the upstream cysteine being required (12-14). Our observations are
suggestive for a function of the N-terminal domain regulating the
activity of the catalytic domain as proposed in Ref. 49. Farnesylation of Ras could induce a topological orientation allowing the
accessibility to the catalytic domain of Cdc25p, where the region
1374-1444 is essential for this interaction (50). Evidence in
vitro and in vivo has indicated that the N-terminal
moiety of mammalian RasGEFs CDC25Mm (38) and SOS (51)
down-regulates the activity of the catalytic region, despite a modular
organization fully different from the N-terminal region of Cdc25p or Sdc25p.
Another relevant aspect of this work is the effect of Ha-Ras
farnesylation on the response to GEF and adenylyl cyclase. As for
Ras2p, farnesylation of Ha-Ras is required for a response to
membrane-associated Cdc25p, but differently from Ras2p, unprenylated Ha-Ras is insensitive to membrane-associated C-Cdc25p 877-1589 and
becomes as responsive as Ras2p only after fusion with the hypervariable
region of Ras2p (residues 182-322). This demonstrates the essential
role of this region for a productive interaction with the C-terminal
domain of Cdc25p and disagrees with a suggested negative regulatory
role of the C-terminal portion of Ras2p, which was proposed from the
observation that Ras proteins lacking the C-terminal domain can bypass
cdc25 mutations (52). We observed that purified C-Cdc25p can
exert a GDP dissociating activity on Ha-Ras or Ha-Ras 1-173/Ras2p
307-322 even better than on Ras2p. These results show that with
membrane-associated components protein interaction becomes subject to
more selective constraints than with soluble components. Differently
from region 8-181 (homologous to region 1-173 in Ha-ras) which is
acidic, the hypervariable region 182-322 displays a highly positive
net charge, that together with the presence of extensive hydrophobic
stretches is likely essential for binding to membrane-associated
GEF.
Ha-Ras p21 was reported to be able to substitute for yeast Ras proteins
in sustaining growth and adenylyl cyclase activation, but
complementation of the defect of yeast Ras genes was not
efficient (53, 54). In our hands unprenylated recombinant Ha-Ras was practically unable to stimulate adenylyl cyclase and only its farnesylation enabled some stimulation. Even with farnesylated Ha-Ras
maximum activation of adenylyl cyclase was much lower than with Ras2p,
an effect that was more pronounced with wild-type adenylyl cyclase than
with its CRI4 mutant. However, farnesylated Ha-Ras showed a
strong affinity for both CRI4 and CYR1 gene
products, almost as high as that of farnesylated Ras2p. In order to
clarify the reasons for the functional differences, we extended the
observations that an activated Ha-Ras Val-12/Ras2p chimaera containing
the first 73 amino acids of Ha-Ras Val-12 stimulates adenylyl cyclase more efficiently than Ha-Ras (53). For this purpose, we constructed two
N-terminal Ha-Ras/C-ter Ras2p chimaeras including C-terminal regions of
Ras2p of different length (Ha-Ras 1-81/Ras2p 89-322 and Ha-Ras
1-173/Ras2p 182-322) comprising the extended hypervariable region of
Ras2p. Both constructs revealed the same profile of adenylyl cyclase
activation as Ras2p, thereby defining the hypervariable domain as an
additional important element for full reconstitution of the activity.
Other major determinants for the interaction with adenylyl cyclase are
the effector region (residues 32-40 in Ha-Ras and 39-47 in Ras2p)
(31, 55-59), its flanking residues and the switch 2 region (31, 58).
By means of the CRI4-encoded product, which is highly
sensitive to Ras2p even if unfarnesylated, we showed that maximum
stimulation of adenylyl cyclase by unprenylated Ras2p or Ha-Ras/Ras2p
chimaeras is identical to that obtained with prenylated Ras2p. This
emphasizes the crucial role of the hypervariable region for maximum
activation and shows that the major effect of farnesylation is to
increase the affinity between Ras2p and adenylyl cyclase rather than to
stimulate adenylyl cyclase activity.
Even if there is still some uncertainty about a direct interaction
between Ras proteins and adenylyl cyclase, due to the need of the
adenylyl cyclase tightly associated protein CAP (60, 61) for a proper
response to post-translationally modified Ha-Ras (22), it is possible
that the basic nature of the C-terminal region of Ras2p could favor an
efficient interaction with the leucine repeat-rich region following the
N-terminal region of adenylyl cyclase. This interaction could induce a
suitable conformation for maximum activation of the catalytic domain.
Leucine-rich repeat regions (61) are critical in mediating
protein-protein interaction (62), as has been recently shown in SUR-8,
a conserved Ras-binding protein that contains this core consensus and
positively regulates Ras-mediated signaling in Caenorhabditis
elegans (63).
Farnesylation of Ras2p is not required for adenylyl cyclase activation,
as has been tested with CRI4-adenylyl cyclase. However, as already
reported for the wild-type CYR1 product (21), farnesylation of
Ras2·GTP increases the affinity for adenylyl cyclase. Compared with
the wild-type one, CRI4-adenylyl cyclase shows not only an increased
sensitivity to Ras2p (26, 46) but also a higher affinity for
farnesylated Ras. One should stress that the differences between these
two adenylyl cyclases are only quantitative.
Adenylyl cyclase is not as strongly associated with the plasma membrane
as Cdc25p and Sdc25p, does not contain a hydrophobic region resembling
a membrane-spanning domain (64) and in ras1ras2bcy1 cells it
is located in the soluble fraction (65). Overexpression of Cdc25p has
been reported to translocate adenylyl cyclase to the membrane fraction
(65), while disruption of IRA1 gene dislocates it from the
membrane (66), indicating that both Cdc25p and Ira1p are involved in
anchoring adenylyl cyclase to the membrane. A complex between the
Cdc25p SH3 domain and adenylyl cyclase not mediated by CAP has been
demonstrated (67). Taken together these data suggest the existence in
the cell of a large oligomeric complex including Cdc25p, Ira1p, and
adenylyl cyclase. The association of Ras2p, Cdc25p, and adenylyl
cyclase (68) is further supported by this work highlighting the common
function of the C-terminal hypervariable region of Ras2p and its
farnesylation in promoting the interaction with and/or activation of
membrane-bound Cdc25p and adenylyl cyclase. However, neither Cdc25p nor
Sdc25p, even when overexpressed, are able to increase the affinity of
farnesylated Ras2p for adenylyl cyclase.
In conclusion, this work shows that the cellular localization of Ras2p,
its regulators Cdc25p and Sdc25p and target adenylyl cyclase requires
structural modifications that are dispensable under conditions of
soluble purified components. We have highlighted the essential role of
Ras2p farnesylation for GEF responsiveness and the involvement of its
C-terminal hypervariable region in the interaction with Cdc25p.
Compared with Ha-Ras, this region has been found to contain structural
elements essential for the activation of adenylyl cyclase, the
farnesylation facilitating this interaction.
 |
ACKNOWLEDGEMENTS |
We are deeply indebted to Drs. M. P. Mayer and C. Dale Poulter for the strain E. coli JM101
transformed with the plasmid pGP14-2/1/2, Drs. B. A. Hatton and
F. R. Cross for the pUH7 marker swap plasmid, Dr. E. Martegani for
the gift of plasmids y Dp-H and pIND25-1, and Drs. M. Jacquet and E. Boy-Marcotte for the gift of plamids pYEDP 1/8/2 and pFC1. We thank our
colleagues Drs. I. M. Krab and C. Giglione for useful discussion
and comments.
 |
FOOTNOTES |
*
This work was supported by contracts BIOTECH BIO4-CT96-1110
from the European Community, Ligue Nationale Française Contre le
Cancer, and Association pour la Recherche sur le Cancer Grant 9846.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dépt. de Chimie, Laboratoire de
Synthèse Organique, Ecole Polytechnique, F-91128 Palaiseau cedex, France.
¶
To whom correspondence should be addressed. Tel.:
33-1-6933-3298; Fax: 33-1-6933-3004; E-mail:
andrea@pmc.polytechnique.fr.
Published, JBC Papers in Press, March 21, 2000, DOI 10.1074/jbc.M000729200
 |
ABBREVIATIONS |
The abbreviations used are:
GEF, guanine
nucleotide exchange factor;
CDC25Mm, mouse RasGRF, a neuronal
RasGEF;
PAGE, polyacrylamide gel electrophoresis;
aa, amino acid;
GTP
S, guanosine 5'-O-(thiotriphosphate);
MES, 4-morpholineethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Satoh, T.,
Nakafuku, M.,
and Kaziro, Y.
(1992)
J. Biol. Chem.
267,
24149-24152
|
| 2.
|
Buchberg, A. M.,
Cleveland, L. S.,
Jenkins, N. A.,
and Copeland, N. G.
(1990)
Nature
347,
291-294
|
| 3.
|
Tanaka, K.,
Nakafuku, M.,
Tamanoi, F.,
Kaziro, Y.,
Matsumoto, K.,
and Toh-e, A.
(1990)
Mol. Cell. Biol.
10,
4303-4313
|
| 4.
|
Parmeggiani, A.,
Mistou, M. Y.,
Jacquet, E.,
Poullet, P.,
and Créchet, J.-B.
(1993)
in
The Ras Superfamilies of GTPases
(Lacal, J. C.
, and McCormick, F., eds)
, pp. 467-488, CRC Press, Inc., Boca Raton, FL
|
| 5.
|
Créchet, J.-B.,
Poullet, P.,
Mistou, M. Y.,
Parmeggiani, A.,
Camonis, J.,
Boy-Marcotte, E.,
Damak, F.,
and Jacquet, M.
(1990)
Science
248,
866-868
|
| 6.
|
Broek, D.,
Toda, T.,
Michaeli, T.,
Levin, L.,
Birchmeier, C.,
Zoller, M.,
Powers, S.,
and Wigler, M.
(1987)
Cell
48,
789-799
|
| 7.
|
Damak, F.,
Boy-Marcotte, E.,
Le-Roscouet, D.,
Guilbaud, R.,
and Jacquet, M.
(1991)
Mol. Cell. Biol.
11,
202-212
|
| 8.
|
Boy-Marcotte, E.,
Ikonomi, P.,
and Jacquet, M.
(1996)
Mol. Biol. Cell
7,
529-539
|
| 9.
|
Matsumoto, K.,
Uno, I.,
Oshima, Y.,
and Ishikawa, T.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2355-2359
|
| 10.
|
Casey, P. J.
(1994)
Curr. Opin. Cell Biol.
6,
219-225
|
| 11.
|
Hancock, J. F.,
Magee, A. I.,
Childs, J. E.,
and Marshall, C. J.
(1989)
Cell
57,
1167-1177
|
| 12.
|
Hancock, J. F.,
Paterson, H.,
and Marshall, C. J.
(1990)
Cell
63,
133-139
|
| 13.
|
Cadwallader, K. A.,
Paterson, H.,
Macdonald, S. G.,
and Hancock, J. F.
(1994)
Mol. Cell. Biol.
7,
4722-4730
|
| 14.
|
Dudler, T.,
and Gelb, H. H.
(1996)
J. Biol. Chem.
271,
11541-11547
|
| 15.
|
Porfiri, E.,
Evans, T.,
Chardin, P.,
and Hancock, J. F.
(1994)
J. Biol. Chem.
269,
22672-22677
|
| 16.
|
Marais, R.,
Light, Y.,
Paterson, H. F.,
and Marshall, C. J.
(1995)
EMBO J.
14,
3136-3145
|
| 17.
|
Mc Geady, P.,
Kuroda, S.,
Shimizu, K.,
Takai, Y.,
and Gelb, M. H.
(1995)
J. Biol. Chem.
270,
26347-26351
|
| 18.
|
Kikuchi, A.,
and Williams, L. T.
(1994)
J. Biol. Chem.
269,
20054-20059
|
| 19.
|
Okada, T.,
Masuda, T.,
Shinkai, M.,
Kariya, K.,
and Kataoka, T.
(1996)
J. Biol. Chem.
271,
4671-4678
|
| 20.
|
Kato, K.,
Cox, A. D.,
Hisaka, M. M.,
Graham, S. M.,
Buss, J. E.,
and Der, C. D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6403-6407
|
| 21.
|
Kuroda, Y.,
Suzuki, N.,
and Kataoka, T.
(1993)
Science
259,
683-686
|
| 22.
|
Shima, F.,
Yamawaki-Kataoka, Y.,
Yanagihara, C.,
Tamada, M.,
Okada, T.,
Kariya, K. I.,
and Kataoka, T.
(1997)
Mol. Cell. Biol.
17,
1057-1064
|
| 23.
|
Sherman, F.,
Fink, G. R.,
and Hicks, J. B.
(1986)
in
Laboratory Course Manual for Methods in Yeast Genetics
(Sherman, F.
, Fink, G. R.
, and Hicks, J. B., eds)
, pp. 61-64, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 24.
|
Pompon, D.,
and Nicolas, A.
(1989)
Gene (Amst.)
83,
15-24
|
| 25.
|
Frascotti, G.,
Coccetti, P.,
Vanoni, M. A.,
Alberghina, L.,
and Martegani, E.
(1991)
Biochem. Biophys. Acta
1089,
206-212
|
| 26.
|
Feger, G.,
De Vendittis, E.,
Vitelli, A.,
Masturzo, P.,
Zahn, R.,
Verrotti, A. C.,
Kavounis, C.,
Pal, G. P.,
and Fasano, O.
(1991)
EMBO J.
10,
349-359
|
| 27.
|
Hill, J.,
Ian, K. A.,
Donald, G.,
and Griffiths, D. A.
(1991)
Nucleic Acids Res.
19,
5791-5793
|
| 28.
|
Ito, H.,
Fukuda, Y.,
Murata, K.,
and Kimura, A.
(1983)
J. Bacteriol.
153,
163-168
|
| 29.
|
Nasmyth, K. A.,
and Reed, I.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
2119-2123
|
| 30.
|
Mirisola, M. G.,
Seidita, G.,
Verrotti, A. C.,
Di Blasi, F.,
and Fasano, O.
(1994)
J. Biol. Chem.
269,
15740-15748
|
| 31.
|
Fasano, O.,
Créchet, J.-B.,
De Vendittis, E.,
Zahn, R.,
Feger, G.,
Vitelli, A.,
and Parmeggiani, A.
(1988)
EMBO J.
7,
3375-3383
|
| 32.
|
Poullet, P.,
Créchet, J.-B.,
Bernardi, A.,
and Parmeggiani, A.
(1995)
Eur. J. Biochem.
227,
537-544
|
| 33.
|
Berben, G.,
Dumont, J.,
Gilliquet, V.,
Bolle, P. A.,
and Hilger, F.
(1991)
Yeast
7,
475-477
|
| 34.
|
Cross, F. R.
(1997)
Yeast
13,
647-653
|
| 35.
|
Rothstein, R. J.
(1983)
Methods Enzymol.
101,
202-211
|
| 36.
|
Créchet, J.-B.,
Bernardi, A.,
and Parmeggiani, A.
(1996)
J. Biol. Chem.
271,
17234-17240
|
| 37.
|
Parrini, M. C.,
Bernardi, A.,
and Parmeggiani, A.
(1996)
EMBO J.
15,
1107-1111
|
| 38.
|
Baouz, S.,
Jacquet, E.,
Bernardi, A.,
and Parmeggiani, A.
(1997)
J. Biol. Chem.
272,
6671-6676
|
| 39.
|
Mayer, M. P.,
Prestwich, G. D.,
Dolence, J. M.,
Bond, P. D.,
Wu, H. Y.,
and Poulter, C. D.
(1993)
Gene (Amst.)
132,
41-47
|
| 40.
|
Reiss, Y.,
Goldstein, J. L.,
Seabra, M. C.,
Casey, P. J.,
and Brown, M. S.
(1990)
Cell
62,
81-88
|
| 41.
|
Créchet, J.-B.,
Poullet, P.,
Bernardi, A.,
Fasano, O.,
and Parmeggiani, A.
(1993)
J. Biol. Chem.
268,
14836-14841
|
| 42.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
|
| 43.
|
Jacquet, E.,
Parrini, M.-C.,
Bernardi, A.,
Martegani, E.,
and Parmeggiani, A.
(1994)
Biochem. Biophys. Res. Commun.
199,
497-503
|
| 44.
|
Kataoka, T.,
Powers, S.,
McGill, C.,
Fasano, O.,
Strathern, J.,
Broach, J.,
and Wigler, M.
(1984)
Cell
37,
437-445
|
| 45.
|
Camonis, J. H.,
Kalékine, M.,
Gondré, B.,
Garreau, H.,
Boy-Marcotte, E.,
and Jacquet, J.
(1986)
EMBO J.
5,
375-380
|
| 46.
|
De Vendittis, E.,
Vitelli, A.,
Zahn, R.,
and Fasano, O.
(1986)
EMBO J.
5,
3657-3663
|
| 47.
|
Tamanoi, F.
(1988)
Biochim. Biophys. Acta
948,
1-15
|
| 48.
|
Garreau, H.,
Geymonat, M.,
Renault, G.,
and Jacquet, M.
(1996)
Mol. Biol. Cell
86,
93-102
|
| 49.
|
Munder, T.,
and Küntzel, H.
(1989)
FEBS Lett.
242,
341-345
|
| 50.
|
Park, W.,
Mosteller, R. D.,
and Broek, D.
(1994)
Mol. Cell. Biol.
14,
8117-8122
|
| 51.
|
Corbalan-Garcia, S.,
Margarit, S. M.,
Galron, D.,
Yang, S-S.,
and Bar-Sagi, D.
(1998)
Mol. Cell. Biol.
18,
880-886
|
| 52.
|
Marshall, M. S.,
Gibbs, J. B.,
Scolnick, E. M.,
and Sigal, I. S.
(1987)
Mol. Cell. Biol.
7,
2309-2315
|
| 53.
|
Broek, D.,
Samiy, N.,
Fasano, O.,
Fujiyama, A.,
Tamanoi, F.,
Northup, J.,
and Wigler, M.
(1985)
Cell
41,
763-769
|
| 54.
|
Kataoka, T.,
Powers, S.,
Cameron, S.,
Fasano, O.,
Golfarb, M.,
Broach, J.,
and Wigler, M.
(1985)
Cell
40,
19-26
|
| 55.
|
Marshall, M. S.,
Gibbs, J. B.,
Scolnick, E. M.,
and Sigal, I. S.
(1988)
Mol. Cell. Biol.
8,
52-61
|
| 56.
|
Schaber, M. D.,
Garsky, V. M.,
Boylan, D.,
Hill, W. S.,
Scolnick, E. M.,
Marshall, M. S.,
Sigal, I. S.,
and Gibbs, J. B.
(1989)
Proteins
6,
306-315
|
| 57.
|
Nassar, N.,
Horn, G.,
Herrmann, C.,
Scherer, A.,
McCormick, F.,
and Wittinghofer, A.
(1995)
Nature
375,
554-560
|
| 58.
|
Akasaka, K.,
Tamada, M.,
Wang, F.,
Kariya, K.,
Shima, F.,
Kikuchi, A.,
Yamamoto, M.,
Shirouzu, M.,
Yokoyama, S.,
and Kataoka, T.
(1996)
J. Biol. Chem.
271,
5353-5360
|
|